Page last updated: 2024-10-30

mesalamine and Polymyositis

mesalamine has been researched along with Polymyositis in 1 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Polymyositis: Diseases characterized by inflammation involving multiple muscles. This may occur as an acute or chronic condition associated with medication toxicity (DRUG TOXICITY); CONNECTIVE TISSUE DISEASES; infections; malignant NEOPLASMS; and other disorders. The term polymyositis is frequently used to refer to a specific clinical entity characterized by subacute or slowly progressing symmetrical weakness primarily affecting the proximal limb and trunk muscles. The illness may occur at any age, but is most frequent in the fourth to sixth decade of life. Weakness of pharyngeal and laryngeal muscles, interstitial lung disease, and inflammation of the myocardium may also occur. Muscle biopsy reveals widespread destruction of segments of muscle fibers and an inflammatory cellular response. (Adams et al., Principles of Neurology, 6th ed, pp1404-9)

Research Excerpts

ExcerptRelevanceReference
"Treating Crohn's disease may lead to improvement in steroid-resistant myositis where the two are associated."1.35Association of idiopathic inflammatory myopathy and Crohn's disease. ( Danko, K; Dezso, B; Gunasekera, W; Kulcsar, I; Lukacs, S; Nagy-Toldi, A; Szabo, N, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Szabo, N1
Lukacs, S1
Kulcsar, I1
Gunasekera, W1
Nagy-Toldi, A1
Dezso, B1
Danko, K1

Other Studies

1 other study available for mesalamine and Polymyositis

ArticleYear
Association of idiopathic inflammatory myopathy and Crohn's disease.
    Clinical rheumatology, 2009, Volume: 28, Issue:1

    Topics: Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Crohn Disease

2009